Timing of Anticoagulation Resumption in Atrial Fibrillation After Ischemic Stroke

Introduction to Anticoagulation Resumption

The European Society of Cardiology recommends resuming anticoagulation based on stroke severity using a stratified timing approach: 1 day after TIA, 3 days after mild stroke, 6-8 days after moderate stroke, and 12-14 days after severe stroke, with mandatory brain imaging to exclude hemorrhagic transformation before initiation 1, 2

For patients with TIA, the American Heart Association suggests starting anticoagulation 1 day after the event, after excluding intracranial hemorrhage with CT or MRI 1, 2
For patients with mild stroke (NIHSS <8), the European Heart Society recommends starting anticoagulation after 3 days 1, 2
For patients with moderate stroke (NIHSS 8-15), the American College of Cardiology suggests starting anticoagulation after 6-8 days 1, 2
For patients with severe stroke (NIHSS ≥16), the European Society of Cardiology recommends starting anticoagulation after 12-14 days 1, 2

The American College of Chest Physicians advises against initiating anticoagulation within 48 hours of acute ischemic stroke with either DOACs or vitamin K antagonists 3, 4
Early anticoagulation (<48 hours) increases the risk of symptomatic intracranial hemorrhage without net benefit 3, 4
The risk of hemorrhagic transformation is approximately 1% per day in the acute period 3, 4

The European Society of Cardiology strongly prefers DOACs over vitamin K antagonists for resumption after stroke 2
DOACs reduce intracranial hemorrhage risk by approximately 56% compared to warfarin 2
Observational data suggest early DOAC initiation (<14 days) may be safer than warfarin 3, 4

The American Heart Association recommends always obtaining brain imaging (CT or MRI) before initiating anticoagulation to exclude hemorrhage 2
For moderate-to-severe strokes, repeat imaging is essential to detect hemorrhagic transformation before starting DOACs 2
Large infarct size predicts higher risk of hemorrhagic transformation and should guide delayed initiation 3, 2

The risk of recurrent stroke in AF patients is 4.8% within the first 2 days and 0.4-1.3% per day in the first 7-14 days 3, 4
AF-related ischemic strokes are more often disabling or fatal than other stroke types 3, 4
The 2-week period after stroke carries both elevated recurrent ischemic stroke risk (8-10%) and symptomatic intracranial hemorrhage risk (2-4%) 3, 4

For patients already on anticoagulation who experience a stroke, the European Society of Cardiology suggests assessing and optimizing adherence to therapy first 2, 5
Consider switching to a different anticoagulant 2
Interrupt anticoagulation for 3-12 days based on multidisciplinary assessment for moderate-to-severe strokes 2

The American College of Cardiology advises against adding aspirin to anticoagulation after stroke unless specific large-vessel disease is suspected and bleeding risk is low, as evidence is lacking 1
Do not use the "1-3-6-12 day rule" rigidly without considering individual patient factors like infarct size and hemorrhagic transformation 3, 4
Do not delay beyond 14 days in most cases, as US guidelines suggest commencing within 14 days is reasonable 3, 4